Last reviewed · How we verify

NCT04700098

Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation

Completed NA Results posted Last updated 17 April 2026
What this trial tests

NA trial testing Internet-based behavioral treatment for insomnia in Chronic Obstructive Pulmonary Disease in 13 participants. Completed in 30 June 2025.

Timeline
14 February 2022
Primary endpoint
31 March 2025
30 June 2025

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment13
Start date14 February 2022
Primary completion31 March 2025
Estimated completion30 June 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

40 and older, any sex, with Chronic Obstructive Pulmonary Disease or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Insomnia Severity Index (ISI) Primary · Baseline to 3-months post-treatment

The ISI is a 7-item self-report questionnaire assessing nature, severity and impact of insomnia symptoms. The total score ranges from 0 to 28, with higher scores indicating worse insomnia severity.

GroupValue95% CI
Internet-based Behavioral Treatment for Insomnia-2.67± 4.62
Online Insomnia Patient Education0.40± 0.55
St. George's Respiratory Questionnaire (SGRQ) Primary · Baseline to 3-months post-treatment

The SGRQ is a 50-item measure assessing disease-specific quality of life. The total SGRQ score, which reflects the overall impact of the disease on quality of life, ranges from 0 to 100, with higher scores indicating greater impairment.

GroupValue95% CI
Internet-based Behavioral Treatment for Insomnia17.15± 3.42
Online Insomnia Patient Education1.57± 15.56

Adverse events — posted to ClinicalTrials.gov

Time frame: From baseline to end of follow-up at 3 months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Internet-based Behavioral Treatment for Insomnia
Serious: 0/8 (0%)
Deaths: 0/8
Online Insomnia Patient Education
Serious: 1/5 (20%)
Deaths: 0/5

Serious adverse events (1 terms)

ReactionSystemInternet-based Behavioral …Online Insomnia Patient Ed…
severe asthma attack requiring hospitalizationRespiratory, thoracic and mediastinal disorders
Other adverse events (1 terms — click to expand)

ReactionSystemInternet-based Behavioral …Online Insomnia Patient Ed…
fallGeneral disorders

Most-reported serious reactions: severe asthma attack requiring hospitalization.

Data from ClinicalTrials.gov NCT04700098 adverse events section.

Sponsor's own description

This study is a randomized controlled trial (RCT) to compare sleep and health-related functioning in Veterans with chronic obstructive pulmonary disease (COPD) and insomnia receiving an Internet-based behavioral treatment for insomnia versus online insomnia patient education. Participants will undergo a sleep and health assessment that will be performed at baseline, post-treatment, and 3-months later. Participants will be randomly assigned to either Internet-based behavioral treatment for insomnia or online insomnia patient education.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04700098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing